VertiFlex announces sale of spinal implant technologies to Stryker

theflyonthewall.com

VertiFlex, a privately held medical device company, announced the sale of certain assets to Stryker Corporation’s Spine Division relating to spinal implants that are not core to the ongoing strategic operations of VertiFlex. The scale and scope of the deal are not disclosed, however, the transaction provides VertiFlex with significant non-dilutive funding to further advance its platform for minimally invasive treatment of spinal stenosis, the company said. VertiFlex said the agreement with Stryker includes up-front cash, contingent payments as well as a long-term licensing agreement.

View Comments (0)